Fused heterotricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3
Fused heterotricyclic compounds, methods of using such compounds in the treatment of hormone sensitive diseases such as prostate cancer, and pharmaceutical compositions containing such compounds.
-
Page/Page column 46
(2008/06/13)
More Articles about upstream products of 178432-25-2